|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Encounter for screening for other viral diseases
ICD-10 (CM) Code and Descriptor
|
Z11.51 |
Encounter for screening for human papillomavirus (HPV)
This code is considered unacceptable as a principal diagnosis.
|
Z1151 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 22.67%
|
43.68%
|
16.40%
|
6.40%
|
3.51%
|
2.33%
|
1.48%
|
0.96%
|
0.76%
|
0.43%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z11.51*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0476
|
HPV COMBO ASSAY CA SCREEN |
7,252
|
7,257
|
|
G0145
|
SCR C/V CYTO,THINLAYER,RESCR |
3,586
|
3,586
|
|
87624
|
HPV HI-RISK TYP POOLED RSLT |
2,871
|
2,872
|
|
G0123
|
SCREEN CERV/VAG THIN LAYER |
2,212
|
2,212
|
|
88142
|
CYTOPATH C/V THIN LAYER |
2,161
|
2,161
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,930
|
1,955
|
|
88175
|
CYTOPATH C/V AUTO FLUID REDO |
1,563
|
1,563
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
762
|
762
|
|
87491
|
CHLMYD TRACH DNA AMP PROBE |
738
|
741
|
|
87591
|
N.GONORRHOEAE DNA AMP PROB |
694
|
695
|
|
Q0091
|
OBTAINING SCREEN PAP SMEAR |
625
|
625
|
|
80061
|
LIPID PANEL |
545
|
545
|
|
G0101
|
CA SCREEN;PELVIC/BREAST EXAM |
534
|
534
|
|
80053
|
COMPREHEN METABOLIC PANEL |
471
|
471
|
|
84443
|
ASSAY THYROID STIM HORMONE |
428
|
428
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
417
|
501
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
325
|
325
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
305
|
305
|
|
87510
|
GARDNER VAG DNA DIR PROBE |
304
|
304
|
|
87480
|
CANDIDA DNA DIR PROBE |
304
|
304
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z11.51 related to the following DRG Codes:
951
|
